BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33408105)

  • 1. Disease-modifying antirheumatic drugs and organising pneumonia.
    Faisal M; Roslan A; Nik Abeed NN; Ban Yu-Lin A
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33408105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Cytokine Profiles of Organizing Pneumonia in Patients with Rheumatoid Arthritis Treated with or without Biologics.
    Kawasumi H; Gono T; Tanaka E; Kaneko H; Kawaguchi Y; Yamanaka H
    J Rheumatol; 2016 Apr; 43(4):738-44. PubMed ID: 26834212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic organizing pneumonia (COP), as presentation of rheumatoid arthritis.
    Cavallasca JA; Caubet M; Helling CA; Tate GA
    Rheumatol Int; 2008 Nov; 29(1):99-101. PubMed ID: 18500458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial.
    Huang RY; Pan HD; Wu JQ; Zhou H; Li ZG; Qiu P; Zhou YY; Chen XM; Xie ZX; Xiao Y; Huang QC; Liu L
    Phytomedicine; 2019 Apr; 57():403-410. PubMed ID: 30851515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organising pneumonia as the first manifestation of rheumatoid arthritis.
    Hoshino C; Satoh N; Narita M; Kikuchi A; Inoue M
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22699479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
    Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature.
    Mori S; Cho I; Koga Y; Sugimoto M
    Mod Rheumatol; 2008; 18(1):60-6. PubMed ID: 18159567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
    Roubille C; Haraoui B
    Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.
    Sakaida H; Komase Y; Takemura T
    Mod Rheumatol; 2010 Dec; 20(6):611-6. PubMed ID: 20585825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
    Kitsuwa S; Matsunaga K; Kawai M; Tsuzi T; Kato K; Tani K; Okubo T
    Ryumachi; 1996 Jun; 36(3):551-8. PubMed ID: 8779792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-associated primary hepatic lymphoma and cranial neuropathy in a patient with rheumatoid arthritis: A case report with clinical follow-up over a 7-year period.
    Park JE; Lee KM; Choi HY; Ahn SE; You MW
    Medicine (Baltimore); 2019 Apr; 98(17):e14997. PubMed ID: 31027052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
    Ochi S; Harigai M; Mizoguchi F; Iwai H; Hagiyama H; Oka T; Miyasaka N
    Mod Rheumatol; 2006; 16(5):316-20. PubMed ID: 17039315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.
    Wisłowska M; Jakubicz D
    Rheumatol Int; 2007 May; 27(7):641-7. PubMed ID: 17235556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients.
    Park EH; Shin A; Ha YJ; Lee YJ; Lee EB; Song YW; Kang EH
    Joint Bone Spine; 2021 Jan; 88(1):105057. PubMed ID: 32711117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of three patients with organizing pneumonia associated with rheumatoid arthritis using clarithromycin and prednisolone.
    Ohe M; Shida H; Horita T; Ito K; Sugiura M; Hattori A; Oku K
    Drug Discov Ther; 2017; 11(4):218-222. PubMed ID: 28867755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.
    Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
    Ann Rheum Dis; 2017 Mar; 76(3):511-520. PubMed ID: 27432356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.